⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29057143 | 0.62 | — | — | |
| SCHEMBL896594 | 0.62 | — | — | |
| SCHEMBL896821 | 0.62 | — | — | |
| SCHEMBL689709 | 0.62 | — | — | |
| SCHEMBL8812846 | 0.61 | — | — | |
| SCHEMBL8361447 | 0.61 | — | — | |
| SCHEMBL422700 | 0.61 | — | — | |
| Hydrochloric Acid SCHEMBL9197819 | 0.59 | — | — | |
| Methoxymethane SCHEMBL6863976 | 0.59 | — | — | |
| SCHEMBL1459286 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1315 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240150371-A1 | Compounds for the Treatment of Kinase-Dependent Disorders | EXELIXIS, INC. | 2024-05-09 | — | — | US | claimed |
| CN-115650827-B | Preparation method, intermediate compound and synthesis method for anthracycline derivatives | 戊言医药科技（上海）有限公司 | 2024-03-15 | — | — | CN | claimed |
| CN-117229158-A | Compound with antibacterial activity | 香港理工大学 | 2023-12-15 | — | — | CN | claimed |
| CN-117143060-A | Compound with antibacterial activity | 香港理工大学 | 2023-12-01 | — | — | CN | claimed |
| WO-2023205680-A1 | PI3Kα INHIBITORS | SYNNOVATION THERAPEUTICS, INC. (US) | 2023-10-26 | — | — | WO | claimed |
| CN-110382492-B | Microbiocidal oxadiazole derivatives | 先正达参股股份有限公司 | 2023-07-14 | — | — | CN | claimed |
| CN-115916759-A | Substituted quinazoline compound, preparation method, pharmaceutical composition and application thereof | 南京红云生物科技有限公司 | 2023-04-04 | — | — | CN | claimed |
| EP-3887371-B1 | ARYL COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTION | HOFFMANN LA ROCHE (CH) | 2023-02-22 | — | — | EP | claimed |
| CN-115697996-A | Alkenyl pyrimidine compound, preparation method and application thereof | 南京红云生物科技有限公司 | 2023-02-03 | — | — | CN | claimed |
| CN-108463460-B | Microbiocidal oxadiazole derivatives | 先正达参股股份有限公司 | 2022-10-28 | — | — | CN | claimed |
| EP-0836595-A1 | TRIAZOLINE AND ISOXAZOLINE BIS-OXIME DERIVATIVES AND THEIR USE AS PESTICIDES | Novartis AG (CH) | 1998-04-22 | — | — | EP | claimed |
| CN-1100426-A | Lysosomal enzyme-cleavable antitumor drug conjugates | BRISTOL MYERS SQUIBB CO (US) | 1995-03-22 | — | — | CN | claimed |
| EP-0280240-B1 | Cephalosporin derivatives, process for their preparation and antibacterial agents | BANYU PHARMA CO LTD (JP) | 1994-09-14 | — | — | EP | claimed |
| US-5000777-A | Imidazole derivatives | CIBA-GEIGY CORPORATION (US) | 1991-03-19 | — | — | US | claimed |
| EP-0164944-B1 | CEPHALOSPORIN DERIVATIVES | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1990-07-11 | — | — | EP | claimed |
| EP-0186525-B1 | CARBAPENEM COMPOUNDS, THEIR PREPARATION AND USE | SANKYO COMPANY LIMITED (JP) | 1990-04-04 | — | — | EP | claimed |
| EP-0305330-A1 | Imidazole derivatives | CIBA-GEIGY AG (CH) | 1989-03-01 | — | — | EP | claimed |
| EP-0212353-A2 | 1-Aryl-5-hydrazino-pyrazoles | BAYER AG (DE) | 1987-03-04 | — | — | EP | claimed |
| EP-0205021-A2 | 5-Amino-4-cyano-1-pyridyl pyrazoles | BAYER AG (DE) | 1986-12-17 | — | — | EP | claimed |
| EP-0039426-B1 | THIATRIAZINE DIOXIDES AND HERBICIDAL COMPOSITIONS CONTAINING THEM | BASF Aktiengesellschaft (DE) | 1984-01-18 | — | — | EP | claimed |